Mapping mA at Individual-Nucleotide Resolution Using Crosslinking and Immunoprecipitation (miCLIP).

Methods Mol Biol

Department of Pharmacology, Weill Medical College, Cornell University, New York, NY, 10065, USA.

Published: February 2018

N -methyladenosine (m6A) is the most abundant modified base in eukaryotic mRNA and has been linked to diverse effects on mRNA fate. Current m6A mapping approaches localize m6A residues to 100-200 nt-long regions of transcripts. The precise position of m6A in mRNAs cannot be identified on a transcriptome-wide level because there are no chemical methods to distinguish between m6A and adenosine. Here, we describe a method for using anti-m6A antibodies to induce specific mutational signatures at m6A residues after ultraviolet light-induced antibody-RNA crosslinking and reverse transcription. Then, we describe how to use these mutational signatures to map m6A residues at nucleotide resolution. Taken together, our protocol allows for high-throughput detection of individual m6A residues throughout the transcriptome.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562447PMC
http://dx.doi.org/10.1007/978-1-4939-6807-7_5DOI Listing

Publication Analysis

Top Keywords

m6a residues
16
m6a
8
mutational signatures
8
mapping individual-nucleotide
4
individual-nucleotide resolution
4
resolution crosslinking
4
crosslinking immunoprecipitation
4
immunoprecipitation miclip
4
miclip -methyladenosine
4
-methyladenosine m6a
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!